Heart Research Australia

At Heart Research Australia we are motivated by one goal: to reduce the devastating impact of heart disease on the community. In partnership with our supporters, we fund pioneering, first-stage research that aims to identify new and better ways to diagnose, treat and prevent cardiovascular disease – Australia’s biggest killer.

As first stage research does not often qualify for government funding, financial support from Heart Research Australia is crucial if these innovative concepts are to be translated into life-saving outcomes.

Some outstanding examples are the SALAMI (Stents as an Alternative to Lytic therapy in Acute Myocardial Infarction) procedure; a trial whereby stents are used as an alternative to clot-busting drugs for the treatment of heart attacks, and ETAMI (Early Triage of Acute Myocardial Infarction); a protocol invented to assess and triage patients in the ambulance, using ECG diagnosis and transmitting results directly to the hospital. ETAMI saves significant time (up to 100 minutes) from incident to treatment and saves heart muscle from irreversible damage by opening the coronary artery earlier. The combination of ETAMI and SALAMI reduced death rates from heart attacks at Royal North Shore Hospital from 30% to 2% and is now standard practice in hospitals around Australia. The positive outcomes of the ETAMI and SALAMI programs were made possible due to funding largely from Gifts in Wills.

Heart disease will impact many of us; ourselves, our loved ones and our friends. Leaving a gift in your Will to Heart Research Australia, is one of the most valuable ways to ensure that medical breakthroughs will continue for the benefit of future generations.

Click here to read more about leaving a gift in your Will to Heart Research Australia